ES247237A1 - UN MÉTODO PARA LA PREPARACION DE GRáNULOS DE ACCIoN PROLONGADA - Google Patents

UN MÉTODO PARA LA PREPARACION DE GRáNULOS DE ACCIoN PROLONGADA

Info

Publication number
ES247237A1
ES247237A1 ES0247237A ES247237A ES247237A1 ES 247237 A1 ES247237 A1 ES 247237A1 ES 0247237 A ES0247237 A ES 0247237A ES 247237 A ES247237 A ES 247237A ES 247237 A1 ES247237 A1 ES 247237A1
Authority
ES
Spain
Prior art keywords
granules
coated
tabletted
medicament
mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0247237A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES247237A1 publication Critical patent/ES247237A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un método par ala preparación de gránulos de acción prolongada de un medicamentoque comprende el recubrimiento de los gránulos de medicamento con una composición que contiene una substancia no tóxicaimpermeableformadora de película que sea muy débilmente soluble en los fluidos del aparato digestivo.
ES0247237A 1958-02-18 1959-02-14 UN MÉTODO PARA LA PREPARACION DE GRáNULOS DE ACCIoN PROLONGADA Expired ES247237A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB523358A GB908282A (en) 1958-02-18 1958-02-18 Coated pharmaceutical granules and tablets thereof

Publications (1)

Publication Number Publication Date
ES247237A1 true ES247237A1 (es) 1959-06-16

Family

ID=9792213

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0247237A Expired ES247237A1 (es) 1958-02-18 1959-02-14 UN MÉTODO PARA LA PREPARACION DE GRáNULOS DE ACCIoN PROLONGADA

Country Status (4)

Country Link
BE (1) BE575775A (es)
BR (1) BR5908484D0 (es)
ES (1) ES247237A1 (es)
GB (1) GB908282A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
GB1598458A (en) * 1977-04-01 1981-09-23 Hoechst Uk Ltd Tableting of microcapsules
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
JP2514078B2 (ja) * 1988-08-22 1996-07-10 エスエス製薬株式会社 圧縮成型製剤
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
CA2558065A1 (en) * 2004-03-04 2005-09-15 Cem Goekhan Artificial fruit
CN110882281B (zh) * 2019-11-30 2023-01-10 江苏艾兰得营养品有限公司 一种益生菌肠溶片剂及其制备方法

Also Published As

Publication number Publication date
GB908282A (en) 1962-10-17
BR5908484D0 (pt) 1973-06-12
BE575775A (es)

Similar Documents

Publication Publication Date Title
SU1706373A3 (ru) Способ получени средства с регулируемым высвобождением активного соединени
US3080294A (en) Sustained release type of pharmaceutical vehicles
FI97445C (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
US4478819A (en) Novel oral preparations
EP0438249B1 (en) Controlled absorption naproxen formulation for once-daily administration
US3082154A (en) Improved free-flowing coated antimalarial salts in particulate form
KR840000230A (ko) 브롬헥신 서방출성 제형의 제조방법
US3562806A (en) Rumen stable medicament and/or nutrient compositions
UA29513C2 (uk) Фармацевтична композиція, що включає (е)-3,5-дигідрокси-7-[4'-4''-фторфеніл-2'-циклопропілхінолін-3'-іл]-6- гептенову кислоту
ES408226A1 (es) Procedimiento para preparar acidos quinazolin-4-il?indol-3-ilaceticos.
GB1235787A (en) Sustained release pharmaceutical tablets
ES247237A1 (es) UN MÉTODO PARA LA PREPARACION DE GRáNULOS DE ACCIoN PROLONGADA
US3128226A (en) Composition for relieving pain
US5322698A (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
US2298122A (en) Digitalis capsule
GB760403A (en) Improvements in or relating to enteric coatings
GB630439A (en) Improvements in or relating to pharmaceutical preparations
US3244596A (en) Coated medicinal agents and coating compositions therefor
US3197370A (en) Pyrilamine tannate compositions
US3398225A (en) Coated 2, 2-dichlorovinyl phosphate and polyvinyl chloride resin anthelmintic compositions
US3326760A (en) Choline salicylate polygalacturonate therapy
US4900559A (en) Stabilized enteric coated aspirin granules and process of preparation
US5049374A (en) Oral (coated bead) dosage form for sodium iodide I-131
EP0159735A1 (en) Pharmaceutical composition containing tetracyclin or doxycyclin salts and a process of preparing such a composition
GB2061111A (en) Long acting pharmaceutical composition